Walleye Trading LLC Mirati Therapeutics, Inc. Transaction History

Walleye Trading LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$41.99 - $62.38 $72,474 - $107,667	1,726 Added 246.92%	2,425 $142,000
Q3 2023 Nov 14, 2023	BUY	$27.8 - $45.35 $19,432 - $31,699	699 New	699 $30,000
Q1 2023 May 15, 2023	BUY	$36.54 - $54.26 $535,128 - $794,637	14,645 New	14,645 $544,000
Q1 2021 May 17, 2021	SELL	$158.92 - $221.61 $18,593 - $25,928	-117 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$162.05 - $240.27 $1.35 Million - $2 Million	-8,340 Reduced 98.62%	117 $26,000
Q4 2019 Feb 14, 2020	BUY	$70.76 - $128.86 $598,417 - $1.09 Million	8,457 New	8,457 $1.09 Million
Q3 2018 Nov 14, 2018	SELL	$47.1 - $62.7 $289,900 - $385,918	-6,155 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$26.05 - $52.4 $160,337 - $322,522	6,155 New	6,155 $303,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.